If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

MLAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,233,470.85

Mesa Laboratories Insider Trading History Chart

Mesa Laboratories Share Price & Price History

^$174.13

▲ +6.51 (3.88%)

As of 03/21/2023 05:23 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Mesa Laboratories Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2023	John Sakys	CFO	Sell	1,000	$165.71	$165,710.00	9,696
3/9/2023	John Sakys	CFO	Sell	400	$169.97	$67,988.00	9,696
2/9/2023	John Sakys	CFO	Sell	1,000	$184.27	$184,270.00	9,696
1/23/2023	John Sakys	CFO	Sell	2,100	$210.19	$441,399.00	9,696
1/13/2023	John Bradley Schmieder	Director	Sell	1,571	$191.31	$300,548.01	68,976
12/8/2022	Shannon Hall	Director	Sell	230	$174.97	$40,243.10	957
11/11/2022	John Bradley Schmieder	Director	Sell	2,500	$175.45	$438,625.00	68,976
8/18/2022	Evan Guillemin	Director	Sell	3,692	$196.12	$724,075.04	28,776
6/21/2022	Brian David Archbold	SVP	Sell	392	$188.22	$73,782.24	813
6/21/2022	Gary M. Owens	CEO	Sell	1,756	$188.22	$330,514.32	21,640
6/21/2022	John Sakys	CFO	Sell	722	$188.22	$135,894.84	8,678
6/7/2022	John James Sullivan	Director	Sell	5,192	$207.76	$1,078,689.92	23,857
4/20/2022	John Sakys	CFO	Sell	72	$250.44	$18,031.68	7,514
3/23/2022	John Sakys	CFO	Sell	930	$251.29	$233,699.70
2/15/2022	John James Sullivan	Director	Sell	5,192	$259.42	$1,346,908.64
1/3/2022	John Bradley Schmieder	Director	Sell	1,000	$327.77	$327,770.00
12/14/2021	Brian David Archbold	SVP	Sell	1,659	$325.02	$539,208.18
12/10/2021	John Sakys	CFO	Sell	1,758	$324.74	$570,892.92
12/2/2021	Evan Guillemin	Director	Sell	2,320	$310.61	$720,615.20
11/15/2021	John James Sullivan	Director	Sell	5,192	$308.02	$1,599,239.84
11/11/2021	John Sakys	CFO	Sell	1,000	$317.12	$317,120.00
11/8/2021	David M. Kelly	Director	Sell	18	$324.07	$5,833.26
11/8/2021	Gregory DiNoia	SVP	Sell	280	$323.72	$90,641.60
10/20/2021	John Sakys	CFO	Sell	2,000	$309.86	$619,720.00
10/1/2021	John James Sullivan	Director	Sell	1,250	$304.48	$380,600.00
9/10/2021	John Sakys	CFO	Sell	1,400	$270.21	$378,294.00	8,914
8/31/2021	David M. Kelly	Director	Sell	603	$267.29	$161,175.87
8/16/2021	John James Sullivan	Director	Sell	5,192	$272.16	$1,413,054.72	28,549
8/12/2021	John Sakys	CFO	Sell	1,000	$275.16	$275,160.00	8,514
8/11/2021	John Bradley Schmieder	Director	Sell	800	$278.06	$222,448.00	70,707
8/9/2021	Brian David Archbold	SVP	Sell	639	$280.03	$178,939.17	154
8/2/2021	John James Sullivan	Director	Sell	1,250	$290.47	$363,087.50
7/16/2021	Evan Guillemin	Director	Sell	720	$282.18	$203,169.60	29,450
7/12/2021	John Sakys	CFO	Sell	1,000	$278.77	$278,770.00	8,514
7/12/2021	John Sakys	CFO	Sell	1,000	$278.77	$278,770.00
7/1/2021	John James Sullivan	Director	Sell	1,250	$267.44	$334,300.00	24,299
6/16/2021	Evan Guillemin	Director	Sell	720	$256.36	$184,579.20	30,170
6/16/2021	Gary M. Owens	CEO	Sell	6,545	$255.67	$1,673,360.15	24,941
6/16/2021	Gregory DiNoia	SVP	Sell	1,211	$255.67	$309,616.37	2,529
6/16/2021	John Sakys	CFO	Sell	2,119	$255.67	$541,764.73	9,633
6/8/2021	John James Sullivan	Director	Sell	5,192	$258.19	$1,340,522.48	29,400
6/7/2021	Gary M. Owens	CEO	Sell	1,350	$264.00	$356,400.00	8,513
6/4/2021	David M. Kelly	Director	Sell	851	$260.28	$221,498.28	2,772
6/4/2021	Gregory DiNoia	SVP	Sell	540	$260.27	$140,545.80	1,380
6/1/2021	John James Sullivan	Director	Sell	2,215	$251.46	$556,983.90	24,208
5/17/2021	Evan Guillemin	Director	Sell	720	$244.25	$175,860.00	30,595
5/6/2021	John James Sullivan	Director	Sell	200	$250.05	$50,010.00	33,059
5/4/2021	John James Sullivan	Director	Sell	735	$250.14	$183,852.90	33,159
4/5/2021	John James Sullivan	Director	Sell	500	$250.76	$125,380.00	57,458
3/16/2021	Evan Guillemin	Director	Sell	720	$269.48	$194,025.60	32,035
3/12/2021	John Sakys	CFO	Sell	2,500	$263.84	$659,600.00	4,850
3/10/2021	Brian David Archbold	SVP	Sell	223	$271.78	$60,606.94	377
3/1/2021	John James Sullivan	Director	Sell	1,250	$273.94	$342,425.00	57,958
2/10/2021	John Bradley Schmieder	Director	Sell	1,750	$278.23	$486,902.50	71,717
2/1/2021	John James Sullivan	Director	Sell	1,250	$277.67	$347,087.50	59,208
1/12/2021	John Bradley Schmieder	Director	Sell	477	$285.23	$136,054.71	73,467
1/6/2021	John Sakys	CFO	Sell	16	$290.00	$4,640.00	3,366
1/4/2021	John James Sullivan	Director	Sell	1,250	$280.82	$351,025.00	60,458
12/11/2020	David M. Kelly	Director	Sell	250	$283.18	$70,795.00	2,350
12/1/2020	John James Sullivan	Director	Sell	1,250	$275.22	$344,025.00	61,708
11/17/2020	John Sakys	CFO	Sell	984	$290.00	$285,360.00	4,334
11/16/2020	David M. Kelly	Director	Sell	704	$283.31	$199,450.24	3,304
11/13/2020	Evan Guillemin	Director	Sell	2,050	$274.30	$562,315.00	36,728
11/11/2020	John James Sullivan	Director	Sell	1,250	$272.36	$340,450.00	62,481
10/8/2020	Gary M. Owens	CEO	Sell	1,000	$275.62	$275,620.00	10,186
10/8/2020	John Sakys	CFO	Sell	942	$276.90	$260,839.80	4,292
10/6/2020	Gary M. Owens	CEO	Sell	1,000	$265.00	$265,000.00	10,863
10/2/2020	Gregory DiNoia	SVP	Sell	332	$260.00	$86,320.00	1,452
9/4/2020	Gregory DiNoia	SVP	Sell	280	$243.55	$68,194.00	1,182
9/1/2020	John Sakys	CFO	Sell	298	$250.00	$74,500.00	3,698
8/31/2020	David M. Kelly	Director	Sell	600	$245.00	$147,000.00	2,990
8/28/2020	David M. Kelly	Director	Sell	180	$244.00	$43,920.00	2,990
8/17/2020	David M. Kelly	Director	Sell	800	$247.72	$198,176.00	3,610
8/17/2020	Gregory DiNoia	SVP	Sell	835	$245.70	$205,159.50	2,297
8/14/2020	John Sakys	CFO	Sell	1,000	$244.00	$244,000.00	4,500
8/10/2020	Brian David Archbold	SVP	Sell	603	$250.00	$150,750.00	415
8/10/2020	David M. Kelly	Director	Sell	1,371	$250.00	$342,750.00	3,154

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Mesa Laboratories (NASDAQ:MLAB)

93.00% of Mesa Laboratories stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mesa Laboratories Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/24/2023	SRS Capital Advisors Inc.	558	$93K	0.0%	-33.3%	0.010%
2/22/2023	Teachers Retirement System of The State of Kentucky	1,526	$0.25M	0.0%	+28.2%	0.029%
2/15/2023	Public Employees Retirement System of Ohio	18,911	$3.14M	0.0%	+16.4%	0.354%
2/15/2023	State of Tennessee Treasury Department	4,290	$0.71M	0.0%	+121.0%	0.080%
2/15/2023	Captrust Financial Advisors	6,856	$1.14M	0.0%	N/A	0.128%
2/15/2023	Jane Street Group LLC	1,664	$0.28M	0.0%	-54.4%	0.031%
2/15/2023	State of Wisconsin Investment Board	5,262	$0.88M	0.0%	+141.4%	0.098%
2/15/2023	Squarepoint Ops LLC	1,268	$0.21M	0.0%	N/A	0.024%
2/15/2023	Legal & General Group Plc	12,673	$2.11M	0.0%	+2.6%	0.237%
2/15/2023	Millennium Management LLC	3,691	$0.61M	0.0%	-11.1%	0.069%
2/15/2023	Morgan Stanley	263,735	$43.84M	0.0%	+808.7%	4.933%
2/15/2023	Eagle Asset Management Inc.	100,056	$17.23M	0.1%	+11.2%	1.872%
2/14/2023	Point72 Asset Management L.P.	78,014	$12.97M	0.0%	+115.8%	1.459%
2/14/2023	Price T Rowe Associates Inc. MD	2,290	$0.38M	0.0%	+34.5%	0.043%
2/14/2023	Amundi	542	$0.10M	0.0%	N/A	0.010%
2/14/2023	Granahan Investment Management LLC	33,894	$5.63M	0.2%	-2.9%	0.634%
2/14/2023	Townsquare Capital LLC	3,395	$0.56M	0.0%	+96.4%	0.063%
2/13/2023	First Republic Investment Management Inc.	4,371	$0.73M	0.0%	+15.0%	0.082%
2/13/2023	Charles Schwab Investment Management Inc.	38,193	$6.35M	0.0%	+3.7%	0.714%
2/13/2023	Deutsche Bank AG	2,594	$0.43M	0.0%	+12.3%	0.048%
2/13/2023	Public Employees Retirement Association of Colorado	3,123	$0.52M	0.0%	N/A	0.058%
2/13/2023	Teton Advisors Inc.	4,000	$0.67M	0.2%	-14.9%	0.075%
2/13/2023	Barclays PLC	2,450	$0.41M	0.0%	+87.7%	0.046%
2/13/2023	Renaissance Technologies LLC	17,934	$2.98M	0.0%	+118.7%	0.335%
2/13/2023	The Manufacturers Life Insurance Company	1,987	$0.33M	0.0%	+3.0%	0.037%
2/13/2023	Credit Suisse AG	9,164	$1.52M	0.0%	+21.8%	0.171%
2/13/2023	Neuberger Berman Group LLC	1,693	$0.28M	0.0%	-4.4%	0.032%
2/13/2023	Geode Capital Management LLC	95,887	$15.94M	0.0%	+3.6%	1.792%
2/13/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	5,369	$0.89M	0.0%	+17.9%	0.100%
2/13/2023	M&T Bank Corp	3,460	$0.54M	0.0%	-16.0%	0.065%
2/10/2023	Bank of America Corp DE	32,439	$5.39M	0.0%	+9.6%	0.606%
2/10/2023	Amalgamated Bank	2,361	$0.39M	0.0%	-2.7%	0.044%
2/10/2023	Sei Investments Co.	7,297	$1.21M	0.0%	-13.5%	0.136%
2/10/2023	Schroder Investment Management Group	95,236	$15.83M	0.0%	-30.0%	1.780%
2/10/2023	Victory Capital Management Inc.	9,063	$1.51M	0.0%	-33.0%	0.169%
2/10/2023	PNC Financial Services Group Inc.	3,975	$0.66M	0.0%	-7.7%	0.074%
2/10/2023	Bahl & Gaynor Inc.	4,854	$0.81M	0.0%	N/A	0.091%
2/9/2023	Victory Capital Management Inc.	10,209	$1.73M	0.0%	-24.5%	0.191%
2/9/2023	Dimensional Fund Advisors LP	78,426	$13.04M	0.0%	+7.4%	1.467%
2/9/2023	Principal Financial Group Inc.	150,522	$25.02M	0.0%	+8.6%	2.816%
2/9/2023	Motley Fool Asset Management LLC	8,556	$1.42M	0.2%	-8.0%	0.160%
2/9/2023	Citigroup Inc.	3,307	$0.55M	0.0%	+21.2%	0.062%
2/8/2023	Raymond James & Associates	58,131	$9.66M	0.0%	+25.2%	1.089%
2/8/2023	UBS Group AG	3,312	$0.55M	0.0%	+53.2%	0.062%
2/8/2023	Cambridge Investment Research Advisors Inc.	5,338	$0.89M	0.0%	+2.2%	0.100%
2/8/2023	Swiss National Bank	12,802	$2.13M	0.0%	+3.2%	0.240%
2/8/2023	Russell Investments Group Ltd.	39,950	$6.64M	0.0%	-24.2%	0.748%
2/8/2023	Arizona State Retirement System	1,500	$0.25M	0.0%	+4.8%	0.028%
2/7/2023	Texas Permanent School Fund	3,357	$0.56M	0.0%	-6.7%	0.063%
2/7/2023	Geneva Capital Management LLC	191,816	$31.88M	0.7%	+83.1%	3.592%
2/7/2023	LPL Financial LLC	1,504	$0.25M	0.0%	N/A	0.028%
2/7/2023	Envestnet Asset Management Inc.	12,597	$2.09M	0.0%	+11.8%	0.236%
2/7/2023	Oppenheimer Asset Management Inc.	1,787	$0.30M	0.0%	-12.4%	0.033%
2/6/2023	Brinker Capital Investments LLC	1,914	$0.32M	0.0%	-23.9%	0.036%
2/3/2023	Cutter & CO Brokerage Inc.	1,395	$0.23M	0.1%	N/A	0.026%
2/2/2023	SG Americas Securities LLC	1,829	$0.30M	0.0%	-61.4%	0.034%
2/1/2023	CWM LLC	156	$26K	0.0%	+116.7%	0.003%
2/1/2023	Conestoga Capital Advisors LLC	574,783	$95.54M	1.8%	+17.8%	10.764%
1/27/2023	Rice Hall James & Associates LLC	14,275	$2.37M	0.1%	-4.2%	0.267%
1/26/2023	Comerica Bank	50,366	$9.27M	0.1%	+11.5%	0.944%
1/25/2023	Alpha Cubed Investments LLC	1,300	$0.22M	0.0%	N/A	0.024%
1/24/2023	Moody Aldrich Partners LLC	11,438	$1.90M	0.4%	-51.0%	0.214%
1/23/2023	Allspring Global Investments Holdings LLC	997	$0.17M	0.0%	-84.1%	0.019%
1/18/2023	Maryland State Retirement & Pension System	2,044	$0.34M	0.0%	N/A	0.038%
1/18/2023	Exchange Traded Concepts LLC	2,981	$0.50M	0.0%	+2.8%	0.056%
1/9/2023	Yousif Capital Management LLC	3,205	$0.53M	0.0%	-21.4%	0.060%
11/22/2022	Teachers Retirement System of The State of Kentucky	1,190	$0.17M	0.0%	N/A	0.022%
11/21/2022	California State Teachers Retirement System	6,519	$0.92M	0.0%	-1.6%	0.122%
11/17/2022	M&T Bank Corp	4,119	$0.58M	0.0%	+5.7%	0.077%
11/16/2022	Kayne Anderson Rudnick Investment Management LLC	145,290	$20.46M	0.1%	-2.0%	2.721%
11/16/2022	Glenmede Trust Co. NA	58,269	$8.21M	0.1%	-13.1%	1.091%
11/16/2022	Balyasny Asset Management LLC	4,338	$0.61M	0.0%	+67.7%	0.081%
11/16/2022	Jane Street Group LLC	3,647	$0.51M	0.0%	+74.9%	0.068%
11/15/2022	Neuberger Berman Group LLC	1,770	$0.25M	0.0%	-3.9%	0.033%
11/15/2022	Alliancebernstein L.P.	14,479	$2.04M	0.0%	+0.4%	0.271%
11/15/2022	State Street Corp	209,343	$29.48M	0.0%	+5.8%	3.922%
11/15/2022	Summit Global Investments	6,000	$0.85M	0.1%	+33.3%	0.112%
11/15/2022	Two Sigma Investments LP	1,898	$0.27M	0.0%	N/A	0.036%
11/15/2022	Vanguard Group Inc.	349,027	$49.15M	0.0%	-0.9%	6.540%
11/15/2022	Price T Rowe Associates Inc. MD	1,703	$0.24M	0.0%	+23.1%	0.032%
11/15/2022	Putnam Investments LLC	23,328	$3.29M	0.0%	-19.6%	0.437%
11/15/2022	Quadrature Capital Ltd	8,969	$1.27M	0.0%	N/A	0.168%
11/15/2022	Martingale Asset Management L P	1,450	$0.21M	0.0%	-66.3%	0.027%
11/15/2022	First Trust Advisors LP	5,500	$0.78M	0.0%	+4.5%	0.103%
11/15/2022	BlackRock Inc.	863,010	$121.54M	0.0%	-2.4%	16.161%
11/15/2022	Citadel Advisors LLC	22,281	$3.14M	0.0%	+384.3%	0.417%
11/14/2022	Teton Advisors Inc.	4,700	$0.66M	0.2%	-6.0%	0.088%
11/14/2022	Royal Bank of Canada	26,435	$3.72M	0.0%	-0.7%	0.495%
11/14/2022	Point72 Hong Kong Ltd	543	$76K	0.0%	N/A	0.010%
11/14/2022	Point72 Asset Management L.P.	36,159	$5.09M	0.0%	N/A	0.678%
11/14/2022	Cubist Systematic Strategies LLC	792	$0.11M	0.0%	N/A	0.015%
11/14/2022	Renaissance Technologies LLC	8,200	$1.16M	0.0%	-37.4%	0.154%
11/14/2022	Nuveen Asset Management LLC	19,254	$2.71M	0.0%	-2.3%	0.361%
11/10/2022	Envestnet Asset Management Inc.	11,270	$1.59M	0.0%	-11.9%	0.211%
11/10/2022	Credit Suisse AG	7,526	$1.06M	0.0%	+1.9%	0.141%
11/10/2022	Teton Advisors Inc.	4,700	$0.66M	0.2%	-6.0%	0.088%
11/10/2022	Quadrant Capital Group LLC	330	$46K	0.0%	+2,650.0%	0.006%
11/10/2022	ExodusPoint Capital Management LP	1,614	$0.23M	0.0%	-10.8%	0.030%
11/10/2022	Dimensional Fund Advisors LP	73,055	$10.29M	0.0%	+3.5%	1.368%
11/10/2022	Tower Research Capital LLC TRC	3,094	$0.44M	0.0%	+1,257.0%	0.058%

Data available starting January 2016

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Today's Range

Now: $174.13

$167.88

$175.66

50 Day Range

MA: $181.25

$163.15

$203.76

52 Week Range

Now: $174.13

$114.21

$266.22

Volume

53,482 shs

Average Volume

64,913 shs

Market Capitalization

$931.60 million

P/E Ratio

N/A

Dividend Yield

0.39%

Beta

0.7

Who are the company insiders with the largest holdings of Mesa Laboratories?: Mesa Laboratories' top insider shareholders include:
John Bradley Schmieder (Director)
John James Sullivan (Director)
Evan Guillemin (Director)
Gary M Owens (CEO)
John Sakys (CFO)
David M Kelly (Director)
Gregory Dinoia (SVP)
Shannon Hall (Director)
Brian David Archbold (SVP)
Learn More about top insider investors at Mesa Laboratories.
Who are the major institutional investors of Mesa Laboratories?: Mesa Laboratories' top institutional shareholders include:
Conestoga Capital Advisors LLC — 10.76%
Morgan Stanley — 4.93%
Geneva Capital Management LLC — 3.59%
Principal Financial Group Inc. — 2.82%
Eagle Asset Management Inc. — 1.87%
Geode Capital Management LLC — 1.79%
Learn More about top institutional investors of Mesa Laboratories stock.
Which major investors are selling Mesa Laboratories stock?: In the previous quarter, MLAB stock was sold by these institutional investors:
Schroder Investment Management Group
Russell Investments Group Ltd.
Moody Aldrich Partners LLC
Allspring Global Investments Holdings LLC
Victory Capital Management Inc.
Victory Capital Management Inc.
SG Americas Securities LLC
Jane Street Group LLC
In the previous year, company insiders that have sold Mesa Laboratories company stock include:
John Bradley Schmieder (Director)
John James Sullivan (Director)
Evan Guillemin (Director)
Gary M Owens (CEO)
John Sakys (CFO)
David M Kelly (Director)
Gregory Dinoia (SVP)
Learn More investors selling Mesa Laboratories stock.
Which major investors are buying Mesa Laboratories stock?: In the last quarter, MLAB stock was acquired by institutional investors including:
Morgan Stanley
Geneva Capital Management LLC
Conestoga Capital Advisors LLC
Point72 Asset Management L.P.
Principal Financial Group Inc.
Raymond James & Associates
Eagle Asset Management Inc.
Renaissance Technologies LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

MLAB Insider Trading

Mesa Laboratories Insider Trading History Chart

Mesa Laboratories Share Price & Price History

Mesa Laboratories Insider Trading History

SEC Filings (Institutional Ownership Changes) for Mesa Laboratories (NASDAQ:MLAB)

Institutional Buying and Selling by Quarter

Mesa Laboratories Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Mesa Laboratories?

Who are the major institutional investors of Mesa Laboratories?

Which major investors are selling Mesa Laboratories stock?

Which major investors are buying Mesa Laboratories stock?